SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Bitcoin (BTC) is a cryptocurrency launched in 2010. Users are able to generate BTC through the process of mining. Bitcoin has a current supply of 20,111,281. The last known price of Bitcoin is 71,086.72423286 USD and is down -3.89 over the last 24 hours. It is currently trading on 12779 active market(s) with $28,515,435,687.36 traded over the last 24 hours. More information can be found at https://bitcoin.org/.

Bitcoin

Bitcoins steep selloff is driving attention, with traders pointing to leveraged long liquidations and broader risk-off pressure. The community is split between buying an oversold dip near technical support and expecting further declines if selling continues.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

Sellas Phase 3 REGAL trial of GPS has reached the 80th event, and the company expects topline results this month, driving intense attention ahead of the AML data readout. Traders celebrated a sharp after-hours move and speculated about a data leak or short covering, while others cautioned that the trial remains blinded and its outcome is unknown.

Strategy, Inc. engages in the development of fixed-income instruments that provide investors varying degrees of economic exposure to bitcoin. It executes bitcoin acquisition, capital management, and capital markets strategies. The company was founded by Michael J. Saylor and Sanjeev K. Bansal on November 17, 1989, and is headquartered in Tysons Corner, VA.

Strategy Inc. - Ordinary Shares - Class A

Strategy

MSCIs decision to remove Strategy from its indexes is fueling concerns about passive fund selling, while Bitcoins decline adds pressure to the stock. Traders debate whether the potential outflows are already priced in and whether the exclusion will materially weaken Strategys Bitcoin-linked financing model.

Microsoft Corp. engages in the development and support of software, services, devices, and solutions. It operates through the following segments: Productivity and Business Processes, Intelligent Cloud, and More Personal Computing. The Productivity and Business Processes segment is composed of products and services relating to productivity, communication, and information services such as Office Commercial, Office Consumer, LinkedIn, and Dynamics business solutions. The Intelligent Cloud segment consists of public, private, and hybrid server products and cloud services for businesses and developers, as well as enterprise and partner services. The More Personal Computing segment refers to products and services including Windows operating system, Windows cloud services, Surface, HoloLens, personal computer accessories, Xbox hardware, Xbox Cloud Gaming, Microsoft News, and Microsoft Edge. The company was founded by Paul Gardner Allen and William Henry Gates, III in 1975 and is headquartered in Redmond, WA.

Microsoft Corporation

Microsoft Corp

A widespread Microsoft 365 outage disrupted Outlook, Teams, Copilot and other services, prompting complaints from users whose work was interrupted. Traders debated whether the prolonged disruption should pressure the stock, which held near flat-to-positive, while some speculated about a cyberattack without confirmation.

XRP (XRP) is a cryptocurrency . XRP has a current supply of 99,985,583,260 with 63,516,606,953 in circulation. The last known price of XRP is 1.03439229 USD and is down -2.16 over the last 24 hours. It is currently trading on 1895 active market(s) with $1,786,076,895.36 traded over the last 24 hours. More information can be found at https://xrpl.org/.

Ripple

XRP is sliding alongside a broader crypto selloff, with traders pointing to risk-off sentiment, inflation and rate-hike concerns, and leveraged liquidations. The steep decline has sparked debate over whether support will hold or losses will deepen, while some holders are buying the dip and others cite stalled regulatory progress and weak demand as reasons for caution.

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

Jensen Huangs resignation and Colette Kresss interim appointment have rattled NVDA shares, with traders also debating potential China chip-export scrutiny and the companys reliance on Huangs leadership. The community is split between buying the selloff on confidence in Nvidias AI business and avoiding the stock amid leadership and regulatory uncertainty.

Zcash (ZEC) is a cryptocurrency . Users are able to generate ZEC through the process of mining. Zcash has a current supply of 16,962,604.07029401. The last known price of Zcash is 956.58767703 USD and is down -2.92 over the last 24 hours. It is currently trading on 670 active market(s) with $828,877,374.43 traded over the last 24 hours. More information can be found at https://z.cash/.

Zcash

Zcashs sharp pullback after a major rally is dominating discussion, with traders debating whether it is a broader crypto-market correction and liquidation flush or a deeper breakdown. Some call the selloff an oversold buying opportunity, while bears point to lost support and continued selling.

Candel Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. Its pipeline includes CAN-2409 and CAN-3110. The company was founded by Estuardo Aguilar-Cordova in 2002 and is headquartered in Needham, MA.

Candel Therapeutics Inc

Candels planned prostate-cancer BLA filing has been pushed to mid-2027 amid FDA discussions and assay refinement, prompting a sharp selloff and criticism of managements communication and credibility. Some traders see the delay as a manufacturing and regulatory hurdle rather than a problem with the clinical data, while others remain concerned about execution and the longer wait.

Coinbase Global, Inc. engages in the provision of a trusted platform that serves as a compliant on-ramp to the onchain economy and enables users to engage in a wide variety of activities with their crypto assets in both proprietary and third-party product experiences enabled by access to decentralized applications. It offers consumers primary financial account for the cryptoeconomy, institutions a full-service prime brokerage platform with access to deep pools of liquidity across the crypto marketplace, and developers a suite of products granting access to build onchain. The company was founded by Brian Armstrong and Fred Ernest Ehrsam in May 2012 and is headquartered in New York, NY.

Coinbase Global Inc - Ordinary Shares - Class A

Coinbase Global Inc

Coinbase is under pressure alongside Bitcoins slide and broader weakness in crypto-linked stocks, with traders highlighting fresh lows and arguing over whether the selloff has further to run or the shares are forming a base. Some also point to COINs underperformance versus Bitcoin and concerns about trading activity, while a smaller group sees an oversold bounce opportunity.

Bitmine Immersion Technologies, Inc. is a technology company focused on acquiring, holding, and actively managing ETH as its primary treasury reserve asset. It prioritizes digital ecosystem services, such as consultancy and advisory works. The company was founded on August 16, 1995 and is headquartered in Las Vegas, NV.

BitMine Immersion Technologies Inc

BMNR is drawing attention amid weakness in Ethereum and broader crypto-linked stocks, with traders focused on its ETH-treasury exposure and the shares decline. The community is split between dip-buyers expecting a recovery and critics questioning Tom Lees strategy, company spending, transparency and buybacks.

statis crypto Watchlist

Ethereum

Solana

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Krsnaa Diagnostics Plans Mumbai Investor Meeting Under SEBI Norms

Krsnaa Diagnostics Limited ( ($IN:KRSNAA) ) just unveiled an announcement. Krsnaa Diagnostics has scheduled a one-on-one physical meeting with inve...

Krsnaa Diagnostics Schedules One-on-One Investor Meet in Mumbai

Krsnaa Diagnostics Limited ( ($IN:KRSNAA) ) just unveiled an update. Krsnaa Diagnostics Limited has informed the stock exchanges that its officials...

Krsnaa Diagnostics Achieves Record Profit, Eyes Future Growth with Rajasthan Expansion

Krsnaa Diagnostics Limited ( ($IN:KRSNAA) ) has provided an update. Krsnaa Diagnostics Limited reported its highest-ever quarterly profit, with a 1...

Bullish Call On Krsnaa Diagnostics: SEBI Analyst Sees Over 30% Upside In The Long-Term

Equity

The analyst sees multi-year compounding potential in earnings and valuations.


Krsnaa Diagnostics Ltd. engages in the provision of diagnostics services. The firm offers radiology, pathology, and teleradiology services. Its services include Pathology, x-ray and CT scan, MRI, USG, Tele-Radiology, Tele-Pathology, and other diagnostics services. The company was founded by Rajendra Khivraj Mutha on December 20, 2010 and is headquartered in Pune, India.

Krsnaa Diagnostics Ltd.

Neutral Sentiment

Krsnaa Diagnostics shares surged 5% on Thursday. Over the last six months, it has gained nearly 19%. SEBI-registered analyst FrontWave Research has flagged it as a ‘smallcap with growth triggers.’The stock has bottomed out on long-term charts, confirmed by Thursday’s big-volume buying. Institutions are showing fresh interest, validating their conviction,&nbsp;<a href="https://stocktwits.com/frontwave">according to FrontWave Research</a>.&nbsp;Fundamental Drivers&nbsp;Krsnaa Diagnostics holds a strong positioning in the public-private partnership (PPP) segment, where it is the only listed player with a bid win ratio of more than 75%.Additionally, FrontWave noted that the Rajasthan mega PPP project is expected to add 42 mother labs, 135 satellite labs, and over 1,300 collection centers, and is projected to contribute annual revenues of ₹300–350 crore starting FY27, providing long-term visibility.&nbsp;Alongside PPP growth, the retail expansion initiative has seen rapid scaling, with touchpoints rising sevenfold in a year to over 2,400. Retail operations currently contribute 6% of revenues and are compounding steadily, with a target of 700 centers by FY27 that would account for 18–20% of total revenue, they added.&nbsp;What Works For Krsnaa?The company’s cost leadership advantage sets it apart. It offers diagnostics services at 70–90% lower prices than its peers, yet maintains margins comparable to industry leaders, according to FrontWave.<stembedurl>https://stocktwits.com/frontwave/message/627442634</stembedurl>Financial PerformanceIn the first quarter (Q1) of FY26, the company reported a 13% rise in revenues at ₹1,930 crore. Profit after tax rose to ₹205 crore, reflecting a 15% year-on-year growth.&nbsp;EBITDA stood at ₹524 crore with a margin of 27%, marking an improvement of 120 basis points compared to the previous year. During the quarter, the company served over 5 million patients and processed 16 million tests.Analyst TakeFrontWave Research noted that on the technical front,&nbsp;<a href="https://stocktwits.com/symbol/KRSNAA.NSE">Krsnaa Diagnostics' stock</a> has broken out from a prolonged consolidation phase, with increasing volumes signaling institutional interest. Fundamentally, the business is supported by annuity-like revenues from PPP contracts, while retail expansion adds higher-margin growth.They expect rerating with multi-year compounding ahead in both earnings and valuations as retail scales and Rajasthan project revenues kick in from FY27. FrontWave has pegged a target price of ₹1,127 to be achieved by March 4, 2026.What Is The Retail Mood?Data on Stocktwits shows that retail sentiment turned ‘bullish’ a day ago on this counter.<figure class="image"><img style="aspect-ratio:807/108;" src="https://news.stocktwits-cdn.com/Screenshot_2025_09_04_125536_png_e4e1ece84c.webp" alt="Screenshot 2025-09-04 125536.png" width="807" height="108"><figcaption>Krsnaa sentiment and message volume on Sep 4 as of 1:00 pm IST. | source: Stocktwits</figcaption></figure>Krsnaa Diagnostics’ shares have declined 5% year-to-date (YTD).&nbsp;For updates and corrections, email newsroom[at]stocktwits[dot]com.

The analyst sees multi-year compounding potential in earnings and valuations.

Current Price	515.15
Prev Close	522.90
Open	514.35
Dividend Yield	0.38%
50-Day Moving Average	529.57
Beta	N/A
Avg. Volume	43,612.41
PE Ratio	17.13

52-Week High	838.00
52-Week Low	463.10
Market Capitalization	16.29B
EPS (Annual)	31.30
Price to Book	1.62
Revenue Per Employee	1.28M

Feed

News

Sentiment

Fundamentals

Info

KRSNAA.NSE Fundamentals